PRIME-ROSE was launched in July 2023 and will be running over 5 years (2023 – 2028). Oslo University Hospital (OUH) in Norway is leading the project with Kjetil Taskén as Coordinator. The consortium consists of altogether 24 partners, including nine beneficiaries and fifteen associated partners. In addition, PRIME-ROSE is part of the Cancer Mission cluster of projects on Diagnosis and Treatment.
HealthcareTech Outlook
(
Editorial
)
(
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
)
(
Jan 2024
)
-
Combining Expertise Across Boarders to Implement Equitable and Sustainable Precision Cancer Medicine(
Jan 2024
)
Cancer Research Horizons
(
United Kingdom
)
(
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
)
(
Jun 2023
)
-
Cancer Research UK joins European precision cancer medicine trial consortium(
Jun 2023
)
Healthtalk.no
(
Norway
)
(
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
)
(
Apr 2023
)
-
Har fått 66 millioner fra EU - dette skal PRIME-ROSE-prosjektet jobbe med(
Apr 2023
)
Helse Sør-Øst RHF / South-Eastern Norway Regional Health Authority
(
Norway
)
(
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
)
(
Apr 2023
)
-
Millionstøtte til prosjekt for persontilpasset kreftbehandling(
Apr 2023
)
MATRIX, Norwegian Centre for Clinical Cancer Research
(
Norway
)
(
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
)
(
Apr 2023
)
-
PRIME-ROSE: EU project receives 6 million EUR from EU Cancer Mission(
Apr 2023
)
